Kidswell Bio Corporation
4584.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥13,234 | ¥13,239 | ¥4,695 | ¥4,474 |
| - Cash | ¥1,542 | ¥2,840 | ¥2,995 | ¥1,318 |
| + Debt | ¥1,134 | ¥1,549 | ¥1,838 | ¥2,034 |
| Enterprise Value | ¥12,827 | ¥11,948 | ¥3,538 | ¥5,189 |
| Revenue | ¥1,556 | ¥1,721 | ¥2,046 | ¥1,286 |
| % Growth | -9.6% | -15.9% | 59% | – |
| Gross Profit | ¥396 | ¥597 | ¥610 | ¥538 |
| % Margin | 25.4% | 34.7% | 29.8% | 41.8% |
| EBITDA | -¥80 | ¥185 | ¥151 | ¥116 |
| % Margin | -5.1% | 10.8% | 7.4% | 9.1% |
| Net Income | -¥97 | ¥157 | ¥167 | ¥54 |
| % Margin | -6.2% | 9.1% | 8.1% | 4.2% |
| EPS Diluted | -1.95 | 3.28 | 3.96 | 1.33 |
| % Growth | -159.5% | -17.2% | 197.7% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |